Apotex Health Corp. (TSX:APTX)
33.39
-0.89 (-2.60%)
At close: Aug 20, 2026
Apotex Health Earnings Call Transcripts
Fiscal Year 2027
-
Q1 fiscal 2027 results were slightly above expectations, with revenue up 2% year-over-year (ex-VLLP), strong Canadian growth, and robust launch execution. Guidance for the year targets upper mid-single-digit revenue growth and a 30% adjusted EBITDA margin, supported by new product launches and portfolio expansion.